Products

PyroMetal

Fire, smoke and explosions. In real time. On your Mac.

pyrometal.anilk.dev App StoreDesign / 3D & AR/VR

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
One-time
No monthly subscription pricing
Launched
4mo ago
2026-07-13 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Real-time fire, smoke & explosion studio for Apple Silicon

    Jul 13 · 4mo agoLaunch page

Store data

App Store
App Store App Store
Update date not synced
Rating
Rating not syncedRating count not synced
New ratings last mo
—
Price & IAP
FreeIAP data not synced
Current version
—Store metadata

Store assets, rating histograms, install tiers, and screenshots are synced from Apple App Store, Google Play, and Chrome Web Store.

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2026-06-11

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Website does not list public plan prices.

Trial: None · Observed 2026-11-06 · Source page

Pages & changes

Tracked since 2026-07-13

Key pages

Weekly snapshots
Home
pyrometal.anilk.dev/ Snapshot 2026-11-06

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does PyroMetal get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is PyroMetal and what platforms does it support?
PyroMetal is catalogued under 3D & AR/VR: Fire, smoke and explosions. In real time. On your Mac. Supported platforms: Mobile App.

Related products in this category

Design / 3D & AR/VR

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.